DIAsource ImmunoAssays S.A. SA

80.9 FTE

DIAsource ImmunoAssays S.A. reported revenue of €16.7m for the 2025 financial year (annual accounts filed with the NBB on 03 Jun 2026), with 80.9 full-time equivalents.

By total assets for 2025, DIAsource ImmunoAssays S.A. ranks in the top half of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0457.934.723 · VAT BE0457934723
1348 Ottignies-Louvain-la-Neuve
active in Manufacture of other pharmaceutical products (NACE 21209)
operating since 23 May 1996 (≈ 30 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of DIAsource ImmunoAssays S.A. shows with a free account.

See the score
Profile
SA Medium · 80.9 FTE since 1996
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€16.7m
Net result−€1.08m
Equity€4.41m
Cash407,712 €
EBITDA556,606 €
Total assets€10.1m
Headcount (avg FTE)80.9
The line marks its sector median: 34.4% (48 companies).

Change 2022 → 2025: Revenue -5 % Equity -18 % Total assets -27 % Headcount (avg FTE) +1 %

Accounts of the company itself (not consolidated).

The full file covers 11 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

DIAsource ImmunoAssays S.A.'s annual accounts

20252024202320222021
Revenue€16.7m
Net result−€1.08m
Equity€4.41m
Cash407,712 €
EBITDA556,606 €
Total assets€10.1m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 03 Jun 2026
  • Year ended 31 Dec 2024filed on 28 May 2025
  • Year ended 31 Dec 2023filed on 30 May 2024
  • Year ended 31 Dec 2022filed on 02 Jun 2023
  • Year ended 31 Dec 2021filed on 10 Jun 2022

DIAsource ImmunoAssays S.A.'s financial analysis

Management and control of DIAsource ImmunoAssays S.A.

4 active director(s) in the register.

DIAsource ImmunoAssays S.A.'s shareholders and holdings →

DIAsource ImmunoAssays S.A.'s publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0457.934.723
VAT number
BE0457934723
Peppol
Registered · 0208:0457934723 · as of 10 Nov 2026
Legal form
SA
Incorporated
23 May 1996
Registered office
1348 Ottignies-Louvain-la-Neuve
Size
Medium · 80.9 FTE
Latest accounts
2025 · filed on 03 Jun 2026
Activity
Manufacture of other pharmaceutical products (NACE 21209)

DIAsource ImmunoAssays S.A. (SA) has been based in Ottignies-Louvain-la-Neuve since 1996, active in: manufacture of other pharmaceutical products. For 2025, it reports revenue of €16.7m, a net loss of €1.08m and equity of €4.41m. With 80.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 43.7%, above the median of its sector (34.4%).

Guide: Checking a Belgian supplier invoice: numbers and IBAN →

Companies similar to DIAsource ImmunoAssays S.A.

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about DIAsource ImmunoAssays S.A.

What is the revenue of DIAsource ImmunoAssays S.A.?

According to the 2025 annual accounts filed with the NBB, the revenue of DIAsource ImmunoAssays S.A. amounts to 16,705,157 €.

What is the VAT number of DIAsource ImmunoAssays S.A.?

In Belgium, the VAT number is the company number prefixed with BE: BE0457934723 for DIAsource ImmunoAssays S.A., if the company is VAT-registered. Its company number (CBE) is 0457.934.723.

Where is the registered office of DIAsource ImmunoAssays S.A.?

According to the CBE register, the registered office of DIAsource ImmunoAssays S.A. is in 1348 Ottignies-Louvain-la-Neuve.

What is the equity of DIAsource ImmunoAssays S.A.?

At the close of the 2025 financial year, the equity of DIAsource ImmunoAssays S.A. amounts to 4,408,904 €, a solvency of 43.7% of total assets.

How many people work at DIAsource ImmunoAssays S.A.?

80.9 full-time equivalents on average according to the 2025 social balance sheet.

Who manages DIAsource ImmunoAssays S.A.?

The register lists 4 active mandates at DIAsource ImmunoAssays S.A.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is DIAsource ImmunoAssays S.A. within its sector?

By total assets for 2025, DIAsource ImmunoAssays S.A. ranks in the top half of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.

Idonis

The full file of DIAsource ImmunoAssays S.A.

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 09 Jul 2026

No credit card, no commitment.

What each plan unlocks →